You have 9 free searches left this month | for more free features.

Multiple Sclerosis, Chronic Progressive

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Sclerosis, Chronic Progressive, High-Intensity Interval Training, Motor Symptoms Trial in Valens (HIIT, MCT)

Recruiting
  • Multiple Sclerosis, Chronic Progressive
  • +2 more
  • HIIT
  • MCT
  • Valens, Sankt Gallen, Switzerland
    Klinik Valens, Valens rehabilitation clinic
Sep 28, 2022

Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Training groupe, PNF,

Completed
  • Multiple Sclerosis, Chronic Progressive
  • Multiple Sclerosis, Primary Progressive
  • Training groupe
  • +3 more
  • Kaposvár, Somogy, Hungary
    Somogy Megyei Kaposi Mór Oktató Kórház
Mar 24, 2022

Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Marseille, Rennes (Magnetic

Recruiting
  • Multiple Sclerosis, Primary Progressive
  • Multiple Sclerosis, Secondary Progressive
  • Magnetic Resonance Imaging
  • +3 more
  • Marseille, France
  • +1 more
Jan 14, 2022

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco

Recruiting
  • Multiple Sclerosis
  • +2 more
  • N-acetyl cysteine
  • Placebo
  • San Francisco, California
    University of California, San Francisco
Mar 22, 2022

Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

Recruiting
  • Secondary Progressive Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
  • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
  • Placebo oral tablet identical to metformin, up to 4 tablets a day
  • Los Angeles, California
    University of California, Los Angeles
May 2, 2022

Measuring Active Microglia in Progressive Multiple Sclerosis

Completed
  • Secondary Progressive Multiple Sclerosis
  • [C11]PK-1195 PET scan
  • New York, New York
    Weill Cornell Medical College
Jan 14, 2022

Microglia in the Pathogenesis of Progressive Multiple Sclerosis

Active, not recruiting
  • Multiple Sclerosis
    • Turku, Finland Proper, Finland
      Turku PET Centre
    Nov 16, 2021

    Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

    Not yet recruiting
    • Multiple Sclerosis (MS)
    • +6 more
    • Clemastine Fumarate
    • Placebo
    • San Francisco, California
      Sandler Neurosciences Building, Neurological Clinical Research U
    Jul 27, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

    Withdrawn
    • Primary Progressive Multiple Sclerosis
    • +2 more
    • Intranasal Foralumab Solution
    • Placebo
    • (no location specified)
    Feb 14, 2022

    Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive Trial in Porto Alegre

    Not yet recruiting
    • Multiple Sclerosis, Chronic Progressive
    • +3 more
    • Nordic Walking (NWG)
    • +2 more
    • Porto Alegre, Rio Grande Do Sul, Brazil
      Universidade Federal do Rio Grande do Sul
    May 17, 2022

    Progressive Multiple Sclerosis Trial in Regina (Exercise Group 1, Exercise Group 2, Exercise Group 3)

    Recruiting
    • Progressive Multiple Sclerosis
    • Exercise Group 1
    • +2 more
    • Regina, Saskatchewan, Canada
      University of Regina
    Aug 8, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Minneapolis, Minnesota
    • +2 more
    Mar 29, 2022

    Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

    Recruiting
    • Progressive Multiple Sclerosis
    • Placebo
    • Masitinib (4.5)
    • Lille, France
    • +1 more
    Jul 1, 2022

    Gray Matter Demyelination in Primary Progressive MS at 7T

    Recruiting
    • Primary Progressive Multiple Sclerosis
      • Hvidovre, Denmark
        Danish Research Centre for Magnetic Resonance
      Jun 5, 2022

      Primary Progressive Multiple Sclerosis Trial in Durham (DUOC-01)

      Recruiting
      • Primary Progressive Multiple Sclerosis
      • DUOC-01
      • Durham, North Carolina
        Duke University Medical Center
      Jan 25, 2022

      Safety of High Dose of Biotin in Progressive Multiple Sclerosis

      Completed
      • Progressive Multiple Sclerosis
      • Non interventional Study
      • Nantes, France
        Nantes University Hospital
      Sep 20, 2021

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston

      Recruiting
      • Primary Progressive Multiple Sclerosis
      • +3 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jul 20, 2021

      Progressive Multiple Sclerosis Trial in Indianapolis (G-EO System (Reha Technology AG: Olten, Switzerland), Conventional

      Completed
      • Progressive Multiple Sclerosis
      • G-EO System (Reha Technology AG: Olten, Switzerland)
      • Conventional Physical Therapy
      • Indianapolis, Indiana
        Neurorehabilitation and Robotics at IU Health Neuroscience Cente
      Jan 20, 2022

      Multiple Sclerosis, Primary Progressive Trial in Bordeaux, Limoges, Poitiers (Clinical assessment, Ecological evaluation,

      Recruiting
      • Multiple Sclerosis, Primary Progressive
      • Clinical assessment
      • +4 more
      • Bordeaux, France
      • +2 more
      Mar 31, 2022

      Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

      Recruiting
      • Secondary Progressive Multiple Sclerosis
      • +2 more
      • Ferumoxytol infusion
      • +2 more
      • Salt Lake City, Utah
        University of Utah Health Imaging and Neurosciences Center
      Jun 22, 2022

      Multiple Sclerosis Trial (Siponimod)

      Available
      • Multiple Sclerosis
      • (no location specified)
      Sep 7, 2021

      MS - a Prospective Cohort Study

      Active, not recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
      • PASS-MS
      • Berlin, Germany
        Experimental and Clinical Research Center, Studienambulanz Neuro
      Aug 9, 2021

      Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Caen (Cognitive rehabilitation,

      Recruiting
      • Relapsing Remitting Multiple Sclerosis
      • Secondary Progressive Multiple Sclerosis
      • Cognitive rehabilitation
      • Standard Psychological care
      • Caen, Calvados, France
        University Hospital of Caen
      Mar 8, 2022

      Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial run by the NIAID (Idebenone)

      Completed
      • Multiple Sclerosis
      • Primary Progressive Multiple Sclerosis
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 27, 2021

      Multiple Sclerosis, Secondary Progressive Trial in Calgary (Hydroxychloroquine Pill, Indapamide Pill)

      Recruiting
      • Multiple Sclerosis, Secondary Progressive
      • Hydroxychloroquine Pill
      • Indapamide Pill
      • Calgary, Alberta, Canada
        Foothills Medical Centre
      May 16, 2022